GSKGLAXF
13F holders, Q2 2025 (June 30)1holders
0new positions
0sold out
$19.05avg. 13F price*
At the end of Q2 2025, 1 institutions reported holding GSK PLC (GLAXF) in their 13F filings, unchanged from Q1 2025. 0 opened new positions and 0 sold out. The largest holder was Aristotle Capital Management, LLC ($60.0M).
- Company
- GSK PLC
- CUSIP
- G3910J179
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
All 13F filers, Q1 2025 → Q2 2025: 68,668 shares bought, net +68,668 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 1 holders
| Aristotle Capital Management, LLC | 0.12% | Add +2.2% | 3,152,006 | $60.0M |
"% of holder's portfolio" is GLAXF's weight in each manager's 13F, not the share of GSK PLC the manager owns.